We are live on ! Find out more
ORIC icon

Oric Pharmaceuticals
ORIC

78 hedge funds and large institutions have $639M invested in Oric Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 35 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 18

1.25% more ownership

Funds ownership: 97.24% → 98.49% (+1.3%)

5% less funds holding

Funds holding: 82 → 78 (-4)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

27% less capital invested

Capital invested by funds: $874M → $639M (-$235M)

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

Holders
78
Holders Change
-4
Holders Change %
-4.88%
% of All Funds
1.36%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
9
Increased
35
Reduced
18
Closed
13
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$981K

Top Buyers

1
EAM
Eventide Asset Management
Massachusetts
+$9.79M
2
BlackRock
BlackRock
New York
+$7.89M
3
AG
Artal Group
Luxembourg
+$6.57M
4
Victory Capital Management
Victory Capital Management
Texas
+$4.36M
5
Morgan Stanley
Morgan Stanley
New York
+$2.92M

Top Sellers

1
ABG
Ally Bridge Group
New York
-$10.1M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$7.49M
3
SFM
Sphera Funds Management
Israel
-$4.16M
4
Jennison Associates
Jennison Associates
New York
-$3.21M
5
State Street
State Street
Massachusetts
-$2.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
Daiwa Securities Group
76
Daiwa Securities Group
Japan
$1K – – –
AIG
77
American International Group
New York
$292 +$72.9K +3,327 +25%
Nisa Investment Advisors
78
Nisa Investment Advisors
Missouri
$59 +$73.4K +3,350 New
ABG
79
Ally Bridge Group
New York
– -$10.1M -413,061 Closed
SFM
80
Sphera Funds Management
Israel
– -$4.16M -169,900 Closed
HF
81
HRT Financial
New York
– -$1.21M -49,514 Closed
California Public Employees Retirement System
82
California Public Employees Retirement System
California
– -$1.11M -45,271 Closed
HS
83
HighVista Strategies
Massachusetts
– -$547K -22,333 Closed
RJA
84
Raymond James & Associates
Florida
– -$412K -16,816 Closed
Squarepoint
85
Squarepoint
New York
– -$253K -10,342 Closed
D.E. Shaw & Co
86
D.E. Shaw & Co
New York
– -$240K -9,812 Closed
M&T Bank
87
M&T Bank
New York
– -$224K -9,153 Closed
CMBA
88
C.M. Bidwell & Associates
Hawaii
– -$165K -6,755 Closed
SG Americas Securities
89
SG Americas Securities
New York
– -$140K -5,695 Closed
Pacer Advisors
90
Pacer Advisors
Pennsylvania
– -$39K -1,572 Closed
Bank of Montreal
91
Bank of Montreal
Ontario, Canada
– -$16K -691 Closed
1 2 3
4

ORIC Hedge Fund Activity: Q2 2021 in Review

78 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Oric Pharmaceuticals (ORIC) for Q2 2021, worth a combined $639M — down 27% from $874M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of ORIC and 9 opened new positions — a net loss of 4 holders — while 18 trimmed existing stakes and 35 added.

The largest buyer was Eventide Asset Management, adding an estimated $9.79M. The largest seller was Ally Bridge Group, exiting entirely with an estimated $10.1M sold.

  • 78 institutional investors held Oric Pharmaceuticals (ORIC) as of Q2 2021, down from 82 in Q1 2021.
  • Funds reported $639M of Oric Pharmaceuticals stock for Q2 2021, down 27% quarter-over-quarter.
  • 9 funds opened new Oric Pharmaceuticals positions in Q2 2021 and 13 closed out, a net change of -4 holders.
  • The largest Oric Pharmaceuticals buyer in Q2 2021 was Eventide Asset Management, an estimated $9.79M added.
  • The largest Oric Pharmaceuticals seller in Q2 2021 was Ally Bridge Group, an estimated $10.1M sold.

Based on aggregated 13F filings for Q2 2021.